Advanced search
1 file | 607.91 KB Add to list

Effect of recombinant human thyroid stimulating hormone on radioactive iodine uptake by thyroid carcinoma in dogs

Author
Organization
Project
Abstract
Background: The high doses of radioiodine-131 (I-131) and, subsequently, the high radioactive burden for dog and environment warrants optimization of I-131 therapy in dogs with thyroid carcinoma (TC). Hypothesis/Objectives: To evaluate the effect of a revised protocol with recombinant human thyroid stimulating hormone (rhTSH) on tumor radioactive iodine uptake (RAIU) in dogs with TC. Animals: Nine client-owned dogs diagnosed with TC. Methods: A prospective cross-over study in which tumor RAIU was calculated and compared at 8 hours (8h-RAIU) and 24 hours (24h-RAIU) after injection of radioactive iodine-123 (I-123), once with and once without rhTSH (ie, 250 mu g, IM, 24 and 12 hours before I-123) in each dog. Simultaneously, serum total thyroxine (TT4) and TSH were measured at baseline (T-0), and 6 (T-6), 12 (T-12), 24 (T-24), and 48 hours (T-48) after the first rhTSH administration. Results: Tumor RAIU was significantly higher at 24 hours with rhTSH compared to no rhTSH (mean difference = 8.85%, 95% CI of [1.56; 16.14]; P = .03), while this was non-significant at 8 hours (mean difference = 4.54%, 95% CI of [0.35; 8.73]; P = .05). A significant change of serum TT4 (median difference T-24 - T-0 = 35.86 nmol/L, interquartile range [IQR] = 15.74 nmol/L) and TSH (median difference T-24 - T-0 = 1.20 ng/mL, IQR = 1.55 ng/mL) concentrations occurred after administration of rhTSH (P < .001). Conclusions and Clinical Importance: Recombinant human TSH could optimize I-131 treatment in dogs with TC by increasing tumor RAIU and thus I-131 treatment efficacy.
Keywords
HUMAN THYROTROPIN, MEDULLARY CARCINOMA, HUMAN TSH, HEALTHY, THERAPY, IOHEXOL, CANINE, INTERFERENCE, SCINTIGRAPHY, SINGLE, dog, nuclear medicine, radioiodine, rhTSH, thyroid tumor

Downloads

  • Veterinary Internal Medicne - 2024 - Scheemaeker - Effect of recombinant human thyroid stimulating hormone on radioactive.pdf
    • full text (Published version)
    • |
    • open access
    • |
    • PDF
    • |
    • 607.91 KB

Citation

Please use this url to cite or link to this publication:

MLA
Scheemaeker, Stephanie, et al. “Effect of Recombinant Human Thyroid Stimulating Hormone on Radioactive Iodine Uptake by Thyroid Carcinoma in Dogs.” JOURNAL OF VETERINARY INTERNAL MEDICINE, vol. 38, no. 4, 2024, pp. 2273–81, doi:10.1111/jvim.17132.
APA
Scheemaeker, S., Peremans, K., Vandermeulen, E., Duchateau, L., Roggeman, T., & Daminet, S. (2024). Effect of recombinant human thyroid stimulating hormone on radioactive iodine uptake by thyroid carcinoma in dogs. JOURNAL OF VETERINARY INTERNAL MEDICINE, 38(4), 2273–2281. https://doi.org/10.1111/jvim.17132
Chicago author-date
Scheemaeker, Stephanie, Kathelijne Peremans, Eva Vandermeulen, Luc Duchateau, Tom Roggeman, and Sylvie Daminet. 2024. “Effect of Recombinant Human Thyroid Stimulating Hormone on Radioactive Iodine Uptake by Thyroid Carcinoma in Dogs.” JOURNAL OF VETERINARY INTERNAL MEDICINE 38 (4): 2273–81. https://doi.org/10.1111/jvim.17132.
Chicago author-date (all authors)
Scheemaeker, Stephanie, Kathelijne Peremans, Eva Vandermeulen, Luc Duchateau, Tom Roggeman, and Sylvie Daminet. 2024. “Effect of Recombinant Human Thyroid Stimulating Hormone on Radioactive Iodine Uptake by Thyroid Carcinoma in Dogs.” JOURNAL OF VETERINARY INTERNAL MEDICINE 38 (4): 2273–2281. doi:10.1111/jvim.17132.
Vancouver
1.
Scheemaeker S, Peremans K, Vandermeulen E, Duchateau L, Roggeman T, Daminet S. Effect of recombinant human thyroid stimulating hormone on radioactive iodine uptake by thyroid carcinoma in dogs. JOURNAL OF VETERINARY INTERNAL MEDICINE. 2024;38(4):2273–81.
IEEE
[1]
S. Scheemaeker, K. Peremans, E. Vandermeulen, L. Duchateau, T. Roggeman, and S. Daminet, “Effect of recombinant human thyroid stimulating hormone on radioactive iodine uptake by thyroid carcinoma in dogs,” JOURNAL OF VETERINARY INTERNAL MEDICINE, vol. 38, no. 4, pp. 2273–2281, 2024.
@article{01JMM92VAGN8CG6KW30TMNB58Q,
  abstract     = {{Background: The high doses of radioiodine-131 (I-131) and, subsequently, the high radioactive burden for dog and environment warrants optimization of I-131 therapy in dogs with thyroid carcinoma (TC). Hypothesis/Objectives: To evaluate the effect of a revised protocol with recombinant human thyroid stimulating hormone (rhTSH) on tumor radioactive iodine uptake (RAIU) in dogs with TC. Animals: Nine client-owned dogs diagnosed with TC. Methods: A prospective cross-over study in which tumor RAIU was calculated and compared at 8 hours (8h-RAIU) and 24 hours (24h-RAIU) after injection of radioactive iodine-123 (I-123), once with and once without rhTSH (ie, 250 mu g, IM, 24 and 12 hours before I-123) in each dog. Simultaneously, serum total thyroxine (TT4) and TSH were measured at baseline (T-0), and 6 (T-6), 12 (T-12), 24 (T-24), and 48 hours (T-48) after the first rhTSH administration. Results: Tumor RAIU was significantly higher at 24 hours with rhTSH compared to no rhTSH (mean difference = 8.85%, 95% CI of [1.56; 16.14]; P = .03), while this was non-significant at 8 hours (mean difference = 4.54%, 95% CI of [0.35; 8.73]; P = .05). A significant change of serum TT4 (median difference T-24 - T-0 = 35.86 nmol/L, interquartile range [IQR] = 15.74 nmol/L) and TSH (median difference T-24 - T-0 = 1.20 ng/mL, IQR = 1.55 ng/mL) concentrations occurred after administration of rhTSH (P < .001). Conclusions and Clinical Importance: Recombinant human TSH could optimize I-131 treatment in dogs with TC by increasing tumor RAIU and thus I-131 treatment efficacy.}},
  author       = {{Scheemaeker, Stephanie and Peremans, Kathelijne and Vandermeulen, Eva and Duchateau, Luc and Roggeman, Tom and Daminet, Sylvie}},
  issn         = {{0891-6640}},
  journal      = {{JOURNAL OF VETERINARY INTERNAL MEDICINE}},
  keywords     = {{HUMAN THYROTROPIN,MEDULLARY CARCINOMA,HUMAN TSH,HEALTHY,THERAPY,IOHEXOL,CANINE,INTERFERENCE,SCINTIGRAPHY,SINGLE,dog,nuclear medicine,radioiodine,rhTSH,thyroid tumor}},
  language     = {{eng}},
  number       = {{4}},
  pages        = {{2273--2281}},
  title        = {{Effect of recombinant human thyroid stimulating hormone on radioactive iodine uptake by thyroid carcinoma in dogs}},
  url          = {{http://doi.org/10.1111/jvim.17132}},
  volume       = {{38}},
  year         = {{2024}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: